Keros Therapeutics Inc (KROS) Earnings Report - Forecasts and Surprise Ratio

Keros Therapeutics Inc
KROS
(Nasdaq - US)
Closed
56.55
-3.80 (-6.30%)
in:usd•As of: Nov 15, 2024 15:59 UTC -5
Pre Market:0+0.00 (0.00%)
Open
60.30
High
60.30
Low
55.24

Quarterly Earnings History

KROS ratio: 42%

100%

KROS beat 8 of 19 last estimates

Date of next report: Feb 26, 2025

Estimate for Q4 24: $-1.14

Implied change from Q3 24: -19.15%

Implied change from Q4 23: -14.93%

Earnings Period	Date Reported	EPS / Forecast	Surprise
Q3 24	Nov 6, 2024	$-1.41 / $-1.26	$-0.15 / -11.9%
Q2 24	Aug 7, 2024	$-1.25 / $-1.23	$-0.02 / -1.63%
Q1 24	May 8, 2024	$-1.21 / $-1.31	$0.1 / 7.63%
Q4 23	Feb 28, 2024	$-1.34 / $-1.38	$0.04 / 2.9%
Q3 23	Nov 6, 2023	$-1.33 / $-1.34	$0.01 / 0.75%
Q2 23	Aug 7, 2023	$-1.27 / $-1.34	$0.07 / 5.22%
Q1 23	May 4, 2023	$-1.26 / $-1.13	$-0.13 / -11.5%
Q4 22	Mar 3, 2023	$-1.09 / $-1.12	$0.03 / 2.68%

Data Vendor: Xignite Logo